Schwann cells express erythropoietin receptor and represent a major target for Epo in peripheral nerve injury

GLIA

Volumn 51, Issue 4, 2005, Pages 254-265

  Li, Xiaoqing ^a   Gonias, Steven L ^b   Campana, W Marie ^a  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Extracellular signal regulated kinase; Glia; JAK2; Proliferation; Real time qPCR

Indexed keywords

CYCLOPHILIN; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; RECOMBINANT ERYTHROPOIETIN; ISOPROTEIN; JAK2 PROTEIN, HUMAN; JAK2 PROTEIN, RAT; MESSENGER RNA; ONCOPROTEIN; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; BIOTINYLATION; CELL ACTIVITY; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; FEMALE; NERVE DEGENERATION; NONHUMAN; PERIPHERAL NERVE INJURY; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; SCHWANN CELL; SCIATIC NERVE; ANIMAL; CELL CULTURE; DISEASE MODEL; DRUG ANTAGONISM; GENETICS; INJURY; MALE; METABOLISM; NERVE REGENERATION; PATHOPHYSIOLOGY; PERIPHERAL NERVE; PHOSPHORYLATION; PHYSIOLOGY; SCIATIC NEUROPATHY; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; AUTOCRINE COMMUNICATION; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN, RECOMBINANT; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; JANUS KINASE 2; MALE; NERVE REGENERATION; PERIPHERAL NERVES; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ERYTHROPOIETIN; RNA, MESSENGER; SCHWANN CELLS; SCIATIC NEUROPATHY; UP-REGULATION;

EID: 25444440082     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20202     Document Type: Article

References (54)

1. Bennett GJ, Xie Y-K. 1988. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87-107.
2. Bernaudin M, Bellail A, Marti HH, Yvon A, Vivien D, Duchatelle I, Mackenzie ET, Petit E. 2000. Neurons and astrocytes express Epo mRNA: oxygen-sensing mechanisms that involve the redox state of the brain. Glia 30:271-278.
3. Bernaudin M, Nedeled AS, Divoux D, MacKenzie ET, Petit E, Schumann-Bard P. 2002. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and is target genes, erythropoietin and VEGF, in the adult mouse brain. J Cereb Blood Flow Metab 22:393-403.
4. Bittorf T, Jaster R, Ludke B, Kamper B, Brock J. 1997. Requirement for JAK2 in erythropoietin-induced signaling pathways. Cell Signal 9:85-89.
5. Bittorf T, Seiler J, Ludtke B, Bushse T, Jaster R, Brock J. 2000. Activation of STAT5 during Epo-directed suppression of apoptosis. Cell Signal 12:23-30.
6. Bleuel H, Hoffmann R, Kaufmann B, Neubert P, Ochlich PP, Schaumann W. 1996. Kinetics of subcutaneous versus intravenous epoetin-beta in dogs, rats and mice. Pharmacology 52:329-338.
7. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A. 2000. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 97:10526-10531.
8. Burden S, Yarden Y 1997. Neuregulins and their receptors: a versatile signaling molecule in organogenesis and oncogenesis. Neuron 18:847-55.
9. Campana WM, Myers RR. 2001. Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury. FASEB J 10.1096/fj.00-0857fje published online June 8, 2001.
10. Campana WM, Myers RR. 2003. Exogenous erythropoietin protects against dorsal root ganglion apoptosis and pain following peripheral nerve injury. Eur J Neurosci 18:1497-1506.
11. Campana WM, Hiraiwa M, O'Brien JS. 1998a. Prosaptide activates the MAPK pathway by a G-Protein-dependent mechanism essential for enhanced sulfatide synthesis by Schwann cells. FASEB J 12:307-314.
12. Campana WM, Misasi R, O'Brien JS. 1998b. Identification of a neurotrophic sequence in erythropoietin. Int J Mol Med 1:235-241.
13. Campana WM, Darin S, O'Brien JS. 1999. Phosphatidylinositol 3-kinase and Akt protein kinase mediate IGF-I and prosaptide induced survival in Schwann cells. J Neurosci Res 57:332-341.
14. Carroll SL, Miller ML, Frohnert PW, Kim SS, Corbett JA. 1997. Expression of neuregulins and their putative receptors, Erb2 and Erb3, is induced during Wallerian degeneration. J Neurosci 17:1642-1659.
15. Celik M, Gokmen N, Erbayraktar S, Akhisaroglu M, Konak S, Ulukus C, Gene S, Gene K, Sagiroglu E, Cerami A, Brines M. 2002. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci USA 99:2258-2263.
16. Cheng C, Zochodne DW. 2002. In vivo proliferation, migration and phenotypic changes of Schwann cells in the presence of myelinated fibers. Neuroscience 115:321-329.
17. Digicaylioglu M, Lipton SA. 2001. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signaling cascades. Nature 412:641-647.
18. Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas LA, Bauer C, Gassmann M. 1995. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA 92:3717-3720.
19. Erickson-Miller CL, Pelus LM, Lord KA. 2000. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation. Stem Cells 18:366-373.
20. Gorio A, Gokmen N, Erbayraktar, Yilmaz O, Madaschi L, Cichetti C, Di Guilio AM, Vardar E, Cerami A, Brines M. 2002. Recombinant erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci USA 99:9450-9455.
21. Hall SM, Gregson NA. 1974. The effects of mitomycin C on remyelination in the peripheral nervous system. Nature 252:303-305.
22. Haroon ZA, Amin K, Jiang X, Acrasoy MO. 2003 A novel role for erythropoietin during fibrin-induced wound healing response. Am J Pathol 163:993-1000.
23. Hiraiwa M, Taylor EM, Campana WM, Darin SJ, O'Brien JS. 1997. Cell death prevention, mitogen-activated protein kinase stimulation, and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides. Proc Natl Acad Sci USA 94:4778-4781.
24. Ide C. 1996. Peripheral nerve regeneration. Neurosci Res 25:101-121.
25. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen O. 1994. Signaling by the cytokine receptor superfamily: JAKs and STATs. TIBS 19:222-227.
26. Keswani S, Buldanlioglu U, Fischer A, Reed N, Polley M, Liang H, Zhou C, Jack C, Leitz G, Hoke A. 2004. A novel endogenous erythropoietin mediated pathway prevents axonal degeneration. Ann Neurol 56:815-826.
27. Konishi Y, Chui D-H, Hirose H, Kunishita T, Tabira T. 1993. Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo. Brain Res 609: 29-35.
28. MacDonald R, Bingham S, Bond BC, Parsons AA, Philpott KL. 2001. Determination of changes in mRNA expression in a rat model of neuropathic pain by Taqman™ quantitative RT-PCR. Mol Brain Res 90:48-56.
29. Marti HH, Wenger RH, Rivas LA, Straumann U, Digicaylioglu M, Henn V, Yonekawa Y, Bauer C, Gassmann M. 1996. Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 8:666-676.
30. Masuda S, Nagao M, Takahata K, Konishi Y, Gallyas F Jr, Tabira T, Sasaki R. 1993. Functional erythropoietin receptor of cells with neural characteristics. Comparison with receptor properties of erythroid cells. J Biol Chem 268:11208-11216.
31. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R. 1994. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 269:19488-19493.
32. Miura Y, Miura O, Ihle JN, Aoki N. 1994. Activation of the mitogen activated protein kinase pathway by the erythropoietin receptor. J Biol Chem 269:29962-29969.
33. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R. 1997. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. 76:105-116.
34. Myers RR. 1998. Morphology of the peripheral nervous system and its relationship to neuropathic pain. In: Yaksh TL, Lynch C III, Zapol WM, Maze M, Biebuyck JF, Saidman LJ, editors. Anesthesia: biologic foundations. Philadelphia, PA: Lippincott-Raven. p 483-514.
35. Myers RR, Yamamoto T, Yaksh TL, Powell HC. 1993. The role of focal nerve ischemia and Wallerian degeneration in peripheral nerve injury producing hyperesthesia. Anesthesiology 78:308-316.
36. Pellegrino RG, Politis MJ, Ritchie JM, Spencer PS. 1986. Events in degenerating cat peripheral nerve: induction of Schwann cell S phase and its relation to nerve fibre degeneration. J Neurocytol 15: 17-28.
37. Prass K, Scharff A, Ruscher K, Lowl D, Muselmann C, Victorov I, Kapinya K, Dirnagl U, Meisel A. 2003. Hypoxia-induced stroke tolerance in the mouse mediated by erythropoietin. Stroke 34:1981-1986.
38. Quelle FW, Sato N, Witthuhn BA, Inhorn RC, Eder M, Miyajima A, Griffin J, Ihle JN. 1994. JAK2 associates with the βc chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 14:4335-4341.
39. Sakanaka A, Wen T-C, Matsuda S, Masuda S, Morishita E, Nagao M, Sasaki R. 1998. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 95:4635-4640.
40. Salicioni AM, Gaultier A, Brownlee C, Cheezum MK, Gonias SL. 2004. Low density lipoprotein receptor-related protein-1 promotes β1 integrin maturation and transport to the cell surface. J Biol Chem 279:10005-10012.
41. Sekiguchi Y, Kikuchi S, Myers RR, Campana WM. 2003. ISSLS Prize Winner: erythropoietin inhibits spinal neuronal apoptosis and pain following nerve root crush. Spine 28:2577-2584.
42. Semenza GL. 2000. Oxygen-regulated transcription factors and their role in pulmonary disease. Respir Res 1:159-162.
43. Shamash S, Reichert F, Rotshenker S. (2002) The cytokine network of Wallerian degeneration: tumor necrosis factor-α, interleukin-la and interleukin-1β. J Neurosci 22:3052-3060.
44. Sirén A-L, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, Keenan S, Gleiter C, Pasquali C, Capobianco A, Mennini T, Heumann R, Cerami A, Ehrenreich H, Ghezzi P. 2001. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 98:4044-1049.
45. Sommer C, Lalonde A, Heckman HM, Rodriguez M, Myers RR. 1995. Quantitative neuropathology of a focal nerve injury causing hyperalgesia. J Neuropathol Exp Neurol 54:635-643.
46. Stewart HJ, Bradke F, Tabernero A, Morrell D, Jessen KR, Mirsky R 1996. regulation of Schwann cell Po expression and DNA synthesis by insulin-like growth factors in vitro. Eur J Neurosci 8:553-564.
47. Stoll G, Jung S, Jander S, van der MP, Hartung HP. 1993. Tumor necrosis factor alpha in immune mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J Neuroimmunol 45:175-182.
48. Stoll G, Mueller HW. 1999. Nerve injury: axonal degeneration and neural regeneration: basic insights. Brain Pathol 9:313-325.
49. Sugawa M, Saakurai Y, Ishikawa-Ieda Y, Suzuki H, Asou H. 2002. Effects of erythropoietin on glial development; oligodendrocyte maturation and astrocyte proliferation. Neurosci Res 44:391-403.
50. Vairano M, Dello Russo C, Pozzoli G, Battaglia A, Scambia G, Tringali G, Aloe-Spiriti MA, Preziosi P, Navara P. 2002. Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. Eur J Neurosci 16:684-692.
51. Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnello A, Viviani B, Marinovich M, Cerami A, Coleman TR, Brines M, Ghezzi P. 2003. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198:971-975.
52. Wagner R, Myers RR. 1996. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience 73:625-629.
53. Waller A. 1850. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog and observations of the alterations produced thereby in the structure of their primitive fibers. Philos Trans R Soc Lond Biol 140:423-438.
54. Yu X, Shacka JJ, Eells JB, Suarez-Quian C, Przygodzki RM, Beleslin-Cokic B, Lin C-S, Nikodem VM, Hempstead B, Flanders KC, Costantini F, Noguchi CT. 2002. Erythropoietin receptor signalling is required for normal brain development. Development 129:505-516.